Sonic Healthcare stock in April (2026) | Analysis, price target & growth

Sonic Healthcare

ASX:SHL

$ 19,77

$-0,10 (-0,50%)

19,77 $

$-0,10 (-0,50%)

End-of-day quote: 04/10/2026

Sonic Healthcare Stock Value

Analysts currently rate ASX:SHL as Outperform.

Outperform

Sonic Healthcare Company Info

EPS Growth 5Y

-1,09%

Market Cap

$9,77 B

Long-Term Debt

$3,41 B

Quarterly earnings

05/21/2026 (E)

Dividend

$1,07

Dividend Yield

5,39%

Founded

1934

Industry

Health Care

Country

Australia

Website

Sonic Healthcare

ISIN Number

AU000000SHL7

Website

http://www.sonichealthcare.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$25,00

26.45%

Last Update: 04/11/2026

Analysts: 15

Highest Price Target $32,00

Average Price Target $25,00

Lowest Price Target $21,10

In the last five quarters, Sonic Healthcare’s Price Target has fallen from $29,13 to $27,30 - a -6,28% decrease. Fourteen analysts predict that Sonic Healthcare’s share price will increase in the coming year, reaching $25,00. This would represent an increase of 26,45%.

Top growth stocks in the health care sector (5Y.)

What does Sonic Healthcare do?

Sonic Healthcare Limited is a provider of medical diagnostic services, operates through a network of local laboratories and various subsidiaries across multiple geographical regions. The company operates based on a management philosophy known as Medical Leadership, which emphasizes professionalism, quality service, and an alignment with the needs of both physicians and patients. Business Segments The company operates across several business segments within the medical diagnostics industry. The...

Business Segments

The company operates across several business segments within the medical diagnostics industry. The company's core offerings include pathology, radiology, and other medical diagnostic services. The company is structured as a federation where each business unit or subsidiary maintains its specialized expertise while aligning with the overarching goals of the organization. This federated model ensures a balance between local operational independence and group-led initiatives focusing on shared resources and operational efficiencies.

Pathology services include a wide range of tests performed in laboratories specializing in hematology, immunology, microbiology, and molecular pathology.

Radiology services provided by the company incorporate advanced imaging technologies that include MRI, CT scans, ultrasound, and X-rays, all tailored to meet the diagnostic needs of referring physicians. The integration of these services allows the company to offer comprehensive diagnostic solutions to its customers.

Additionally, the company's laboratory services extend to specialized diagnostic offerings including genetic testing, which is becoming increasingly essential in modern medicine for personalized patient care and targeted treatments. This commitment to a holistic medical approach supports the company's strategy to provide services tailored to evolving medical needs.

Business Strategy

The company’s business strategy focuses on the concept of Medical Leadership and a federated model that respects the local needs and expertise of its subsidiaries while leveraging the strengths of the larger organization for collective success. The company prioritizes continued organic growth through innovative practices and expansive diagnostic services that are well-aligned with contemporary healthcare trends and requirements.

In pursuing its growth objectives, the company aims to continuously enhance its service offerings by investing in new technologies and diagnostic capabilities that keep pace with the advancements in healthcare. This is achieved through a systematic approach to research and investment into innovation, prioritizing the incorporation of advanced diagnostic tools and methodologies.

The company’s strategic acquisition of complementary businesses is another critical facet of its growth strategy. By integrating new capabilities, the company strengthens its foothold in existing markets and expands its reach into new geographical territories. Importantly, the company's approach to acquisitions emphasizes the preservation of local operations and maintain brand recognition.

Products and Services

The company is dedicated to providing a comprehensive range of medical diagnostic services that are essential components of modern healthcare. The primary products and services encompass pathology, radiology, genetic testing, and various specialized laboratory services.

In the field of pathology, the company offers an extensive suite of testing options, including but not limited to hematology, biochemistry, immunology, microbiology, and anatomical pathology. Each of these areas is managed by qualified professionals who adhere to stringent quality standards to ensure accurate and timely results.

The radiology division employs state-of-the-art imaging technologies and innovative diagnostic methodologies to facilitate early detection and treatment of medical conditions. Various modalities, including MRI, CT scans, ultrasound, and X-ray imaging, are utilized to deliver critical information to physicians regarding patient health.

The company's genetic testing services reflect a commitment to personalized medicine. Providing genetic assays that aid in understanding hereditary conditions and developing tailored treatment plans aligns with the growing demand for precision healthcare solutions.

Moreover, the company's laboratory services extend to diagnostic testing to support chronic disease management, infectious disease identification, and treatment compliance monitoring. By offering extensive testing capabilities, the company is well-positioned to serve diverse patient populations through all stages of care.

Geographical Markets Served

The company operates globally across numerous geographical markets, including significant operations in countries such as Australia, the United States, the United Kingdom, New Zealand, Germany, Switzerland, and Belgium. The company has successfully expanded its footprint in the healthcare industry since its inception, driven by strategic acquisitions and partnerships tailored to regional healthcare needs.

Recent strategic moves include the acquisition of Synlab Suisse, finalized on 3 July 2023. This acquisition, valued at CHF150 million, represents the company’s ongoing commitment to enhancing its service offerings and expanding its operational capacity in the medical diagnostics sector.

Seasonality

The company typically experiences certain seasonal patterns in its operations, heavily influenced by the healthcare industry's cyclic demand. Seasonal trends are most visible in pathology and laboratory services, where there may be fluctuations in patient volumes correlated with specific times of the year, such as flu seasons or public health campaigns targeting vaccinations and disease prevention.

These patterns can affect overall service delivery and operational efficiencies, which the company addresses proactively through resource planning and operational adjustments to meet surges or declines in demand.

Customers

The company primarily serves a diverse array of customers, including hospitals, medical practices, pharmacists, and individual patients. By providing vital diagnostic services, the company plays a crucial role in the healthcare continuum, facilitating critical decision-making for treating physicians and healthcare professionals.

Sales and Marketing

The company utilizes a multifaceted approach to its marketing and distribution channels, designed to effectively reach a diverse range of clients and healthcare providers. The marketing strategy focuses on establishing strong relationships with healthcare practitioners, hospitals, and medical facilities to position the company as the preferred provider of diagnostic services.

This approach includes outreach programs, educational seminars, and partnerships with key health organizations to enhance awareness of services and promote the benefits of diagnostic testing. Additionally, the company emphasizes digital marketing channels to engage a broader audience and enhance its visibility in the healthcare field.

Effective distribution of services relies on a robust network of regional laboratories and facilities ensuring that health practitioners and patients have timely access to essential diagnostic services. By effectively combining relationship building, education, and digital marketing, the company maintains its position as a leading provider in the medical diagnostic sector.

History

Sonic Healthcare Limited was incorporated in 1934.

Sonic Healthcare Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Diagnostic revenues:** 70% **Pathology and laboratory services:** 20% **Imaging and radiology:** 10% **TOP 3 Markets:** **USA:** 40% **Australia:** 30% **Germany:** 20% Sonic Healthcare Limited generates the majority of its revenues from the diagnostics industry, particularly throu...

At which locations are the company’s products manufactured?

**Production Sites:** Global, with a focus on Australia, Europe, and North America. Sonic Healthcare Limited is a globally operating company in the field of medical diagnostics and laboratory services. It operates a variety of laboratories and diagnostic facilities in different countries. The main...

What strategy does Sonic Healthcare pursue for future growth?

**Revenue Growth:** 7.8% (2024) **Profit Growth:** 6.5% (2024) Sonic Healthcare Limited pursues a growth strategy based on expanding its global network of laboratory and pathology services. The company relies on strategic acquisitions to strengthen its market presence in existing and new geographic...

Which raw materials are imported and from which countries?

**Commodities/Materials:** Laboratory reagents, medical devices, consumables **Countries of origin:** USA, Germany, Japan Sonic Healthcare Limited mainly imports laboratory reagents, medical devices, and consumables required for its diagnostic services. These materials primarily come from the USA,...

How strong is the company’s competitive advantage?

**Market share:** 25% (estimated, 2025) **EBITDA margin:** 18% (2024) **R&D expenses:** 5% of revenue (2024) Sonic Healthcare Limited has a significant competitive advantage due to its strong market presence and high market share of approximately 25% in the field of medical diagnostics. The...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** approximately 55% (2025, estimated) **Insider Buys/Sells:** No significant insider transactions in the last year (2025, estimated) The institutional investor share in Sonic Healthcare Limited is around 55%. This demonstrates the confidence of large investors in th...

What percentage market share does Sonic Healthcare have?

**Market Share of Sonic Healthcare Limited:** 12% (2025, estimated) **Top Competitors and Their Market Shares:** 1. **Laboratory Corporation of America Holdings (LabCorp):** 15% 2. **Quest Diagnostics Incorporated:** 14% 3. **Sonic Healthcare Limited:** 12% 4. **Eurofins Scientific:** 10% 5. **Synl...

Is Sonic Healthcare stock currently a good investment?

**Revenue Growth:** 8.5% (2024) **Profit Growth:** 7.2% (2024) **Market Share in the Diagnostics Industry:** 12% (2024) Sonic Healthcare Limited recorded solid revenue growth of 8.5% in 2024, attributed to continuous expansion in international markets and increasing demand for diagnostic servic...

Does Sonic Healthcare pay a dividend – and how reliable is the payout?

**Dividend yield:** 3.5% (estimated for 2025) **Dividend history:** Continuous payout over the last 10 years Sonic Healthcare Limited has pursued a reliable dividend policy in the past, with regular payouts to shareholders. The dividend yield for 2025 is estimated to be around 3.5%, which is in...

New support ticket

Explore

Sonic Healthcare Stock Value

Sonic Healthcare Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Sonic Healthcare do?

Sonic Healthcare Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Sonic Healthcare Stock Value

Sonic Healthcare Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Sonic Healthcare do?

Sonic Healthcare Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.